Ankaferd Blood Stopper for Controlling Gastrointestinal Bleeding due to Distinct Benign Lesions Refractory to Conventional Antihemorrhagic Measures

Ankaferd Blood Stopper for Controlling Gastrointestinal Bleeding due to Distinct Benign Lesions Refractory to Conventional Antihemorrhagic Measures

OBJECTIVE: To assess the hemostatic efficacy of the Ankaferd Blood Stopper (ABS, Ankaferd Health Products Ltd, Turkey) hemostatic agent for controlling gastrointestinal bleeding associated with various benign lesions refractory to conventional antihemorrhagic measures.

Saved in:
Bibliographic Details
Main Authors: Mevlut Kurt, Ibrahim Koral Onal, Meral Akdogan, Murat Kekilli, Mehmet Arhan, Abdurrahim Sayilir, Erkin Oztas, Ibrahim Celalettin Haznedaroglu
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2010/896819
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://dx.doi.org/10.1155/2010/896819

Similar Items